A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(5 sites)

United States

Research Site, Glendale, California

Research Site, Inverness, Florida

Research Site, Jacksonville, Florida

Research Site, Brooklyn, Maryland

Research Site, San Antonio, Texas